11 January 2022

Rutherford Health plc

Results of General Meeting

Rutherford Health plc (AQSE: RUTH, the "Company" or "Group"), a healthcare group committed to providing innovative cancer care of the highest quality, announces that at the general meeting held earlier today, all resolutions were passed with the requisite majorities.

The proxy results were as follows:

 

For

%

Against

%

Withheld

Resolution 1 - 

withdrawal from AQSE

57,672,636

84.6%

10,520,949

15.4%

109,163,381

Resolution 2 -

authority to issue shares

166,836,017

94.1%

10,520,949

5.9%

0

Resolution 3 -

disapplication of pre-emption rights

166,836,017

94.1%

10,520,949

5.9%

0

As a result, the last day of dealing in the Company's Ordinary Shares will be 24 January 2022 and withdrawal of the Company's Ordinary Shares from trading on AQSE will take place at 08.00 on 25 January 2022.

In addition, the Company is now able to issue Ordinary Shares a non pre-emptive basis up to a nominal amount of £20,136.37 (being up to 20,136,370 Ordinary Shares) and can therefore now conclude the proposed £2 million convertible loan facility with LF Equity Income Fund announced on 16 December 2021.

The circular dated 22 December 2021 ("the Circular"), which contains the notice convening the General Meeting, is available from the Company's website, www.rutherfordhealth.com

Any capitalised terms not defined in this announcement shall have the same meaning as those defined in the Circular.

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

VIEW ANNOUNCEMENT ON AQSE